Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

David Badesch

Concepts (497)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hypertension, Pulmonary
103
2021
1648
7.930
Why?
Antihypertensive Agents
32
2019
442
3.640
Why?
Epoprostenol
23
2015
126
2.440
Why?
Vasodilator Agents
12
2015
323
1.470
Why?
Registries
18
2021
1739
1.280
Why?
Piperazines
8
2014
308
1.190
Why?
Sulfones
7
2012
98
1.180
Why?
Pulmonary Wedge Pressure
8
2020
70
1.170
Why?
Scleroderma, Systemic
7
2021
86
1.010
Why?
Exercise Tolerance
18
2021
233
1.010
Why?
Connective Tissue Diseases
5
2018
51
1.000
Why?
Sulfonamides
13
2018
397
0.940
Why?
Vascular Resistance
7
2021
378
0.930
Why?
Hemodynamics
28
2015
1069
0.910
Why?
Practice Guidelines as Topic
7
2020
1541
0.890
Why?
Exercise Test
11
2020
596
0.860
Why?
Phenylpropionates
5
2011
18
0.850
Why?
Familial Primary Pulmonary Hypertension
12
2021
149
0.820
Why?
Respiratory System Agents
1
2019
15
0.790
Why?
Natriuretic Peptide, Brain
9
2021
89
0.780
Why?
Pyridazines
5
2011
58
0.770
Why?
Endothelin Receptor Antagonists
10
2015
63
0.730
Why?
Pulmonary Artery
13
2012
1078
0.720
Why?
Humans
129
2021
109171
0.620
Why?
Middle Aged
71
2021
28539
0.580
Why?
Adult
66
2021
31455
0.580
Why?
Disease Management
6
2016
595
0.540
Why?
Thrombosis
1
2016
244
0.540
Why?
Anemia, Sickle Cell
5
2014
184
0.530
Why?
Lung Transplantation
9
2002
332
0.530
Why?
Anticoagulants
3
2016
509
0.500
Why?
Consensus
1
2014
398
0.500
Why?
Double-Blind Method
20
2021
1691
0.480
Why?
Female
79
2021
61606
0.460
Why?
Prognosis
16
2021
3445
0.460
Why?
Risk Assessment
13
2021
3086
0.460
Why?
Male
82
2021
60174
0.460
Why?
Cardiac Catheterization
11
2020
537
0.440
Why?
Prostaglandins
3
2007
88
0.430
Why?
Thinness
1
2011
89
0.430
Why?
Aged
37
2021
19759
0.430
Why?
Activities of Daily Living
3
2016
372
0.410
Why?
Oxygen Consumption
1
2012
644
0.400
Why?
Hypertension, Portal
4
2011
62
0.400
Why?
Blood Pressure
8
2014
1703
0.390
Why?
Sildenafil Citrate
8
2014
54
0.380
Why?
Coagulants
1
2008
7
0.380
Why?
Factor VIIa
1
2008
16
0.380
Why?
Pyrimidines
3
2018
378
0.380
Why?
Survival Rate
14
2018
1821
0.380
Why?
Lung Neoplasms
1
2021
2151
0.370
Why?
Surveys and Questionnaires
2
2018
4375
0.370
Why?
Purines
8
2014
151
0.350
Why?
Mixed Connective Tissue Disease
2
2010
8
0.340
Why?
Treatment Outcome
25
2015
8928
0.340
Why?
Prospective Studies
16
2021
5942
0.330
Why?
Depressive Disorder
1
2010
376
0.330
Why?
Quality of Life
10
2021
1972
0.320
Why?
Evidence-Based Medicine
4
2019
732
0.320
Why?
Health Status
2
2016
765
0.320
Why?
Hemorrhage
2
2008
533
0.310
Why?
Pulmonary Medicine
3
2019
84
0.300
Why?
Phosphodiesterase 5 Inhibitors
3
2014
35
0.300
Why?
Castleman Disease
1
2003
16
0.270
Why?
Pulmonary Disease, Chronic Obstructive
1
2012
1183
0.270
Why?
Adolescent
22
2021
18208
0.260
Why?
Herpesvirus 8, Human
1
2003
69
0.260
Why?
Dose-Response Relationship, Drug
11
2021
2256
0.260
Why?
Follow-Up Studies
15
2018
4830
0.260
Why?
Body Mass Index
1
2011
2073
0.260
Why?
Phosphodiesterase Inhibitors
4
2009
102
0.250
Why?
Ventricular Function, Right
5
2009
232
0.250
Why?
Biomarkers
6
2021
3365
0.250
Why?
Hospitalization
5
2021
1580
0.240
Why?
United States
19
2021
11627
0.240
Why?
Muscle, Smooth, Vascular
6
1994
492
0.240
Why?
Pyrazoles
2
2015
337
0.240
Why?
Insulin-Like Growth Factor I
4
1994
271
0.240
Why?
Herpesviridae Infections
1
2003
170
0.240
Why?
Fluid Shifts
1
2020
5
0.230
Why?
Lung
7
2019
3515
0.220
Why?
Walking
8
2014
379
0.220
Why?
Methamphetamine
1
2021
63
0.220
Why?
Rituximab
1
2021
165
0.220
Why?
Drug Therapy, Combination
6
2014
1021
0.210
Why?
Somatomedins
2
1990
27
0.210
Why?
Infusions, Intravenous
7
2009
431
0.210
Why?
Vasculitis
2
1998
86
0.210
Why?
Echocardiography
4
2020
630
0.210
Why?
Disease Progression
5
2015
2435
0.200
Why?
Thorax
1
2019
47
0.200
Why?
Diagnostic Techniques, Respiratory System
1
2019
5
0.200
Why?
Endothelin A Receptor Antagonists
2
2011
23
0.200
Why?
HLA-DP alpha-Chains
1
2018
3
0.200
Why?
Sodium Chloride
1
2020
171
0.200
Why?
SOXF Transcription Factors
1
2018
17
0.200
Why?
Isoxazoles
3
2008
50
0.200
Why?
Young Adult
10
2021
10686
0.190
Why?
Immunologic Factors
1
2021
237
0.190
Why?
Liver Diseases
3
2011
271
0.190
Why?
Thiophenes
3
2008
107
0.190
Why?
Administration, Oral
9
2015
796
0.190
Why?
HLA-DP beta-Chains
1
2018
110
0.180
Why?
Peptide Fragments
4
2021
703
0.180
Why?
Transforming Growth Factor beta
1
2021
462
0.180
Why?
Algorithms
5
2019
1554
0.180
Why?
Recombinant Fusion Proteins
1
2021
680
0.180
Why?
Blood Coagulation
2
2016
203
0.180
Why?
Drug Monitoring
1
2019
217
0.170
Why?
Obesity
1
2011
2587
0.170
Why?
Time Factors
14
2018
7096
0.170
Why?
Severity of Illness Index
9
2014
2806
0.170
Why?
Psychometrics
2
2018
640
0.170
Why?
Oxygen Inhalation Therapy
1
2018
156
0.160
Why?
Comorbidity
5
2019
1580
0.160
Why?
Diagnostic Imaging
1
2019
277
0.160
Why?
Pyridines
2
2015
465
0.160
Why?
B-Lymphocytes
1
2021
762
0.160
Why?
Iloprost
2
2006
38
0.160
Why?
Hemolysis
2
2014
132
0.150
Why?
Cohort Studies
7
2020
4804
0.150
Why?
Tetrazoles
1
2015
29
0.150
Why?
Pulmonary Edema
1
1995
158
0.150
Why?
Patient Reported Outcome Measures
1
2016
197
0.140
Why?
Pilot Projects
4
2010
1391
0.140
Why?
Graft Rejection
1
1998
603
0.140
Why?
Delphi Technique
1
2014
127
0.140
Why?
Survival Analysis
8
2018
1414
0.140
Why?
Case-Control Studies
5
2018
3324
0.130
Why?
Acute Disease
3
2008
993
0.130
Why?
Antibodies, Antinuclear
1
1993
71
0.130
Why?
Hypothyroidism
1
1993
72
0.130
Why?
Extracorporeal Membrane Oxygenation
1
1995
211
0.130
Why?
Societies, Medical
2
2015
756
0.130
Why?
Models, Theoretical
2
2015
619
0.130
Why?
Echocardiography, Doppler
2
2014
128
0.130
Why?
Incidence
5
2015
2353
0.130
Why?
Respiratory Function Tests
5
2018
581
0.130
Why?
Endpoint Determination
2
2010
77
0.120
Why?
Protein Kinase C
2
1994
359
0.120
Why?
Randomized Controlled Trials as Topic
4
2009
1114
0.120
Why?
Risk Factors
9
2018
8786
0.120
Why?
Proportional Hazards Models
5
2015
1099
0.120
Why?
Survival
1
2011
42
0.120
Why?
United Kingdom
3
2021
232
0.120
Why?
Long-Term Care
1
2011
69
0.120
Why?
Pulmonary Circulation
3
2018
462
0.120
Why?
Peptidyl-Dipeptidase A
3
2003
51
0.110
Why?
Prevalence
4
2010
2329
0.110
Why?
Respiration, Artificial
1
1995
551
0.110
Why?
Diagnosis, Differential
3
2020
1459
0.110
Why?
Michigan
1
2010
99
0.110
Why?
Pain
2
2011
744
0.110
Why?
Reference Values
2
2009
890
0.100
Why?
Animals, Newborn
5
1994
869
0.100
Why?
Endothelin-1
2
2002
163
0.100
Why?
Exercise
3
2018
1608
0.100
Why?
Guideline Adherence
2
2018
522
0.100
Why?
Aldosterone
1
2009
47
0.100
Why?
Elastin
1
1989
69
0.100
Why?
Dinoprostone
1
1989
179
0.100
Why?
Pulmonary Alveoli
2
2005
380
0.100
Why?
Pulmonary Eosinophilia
1
1989
27
0.100
Why?
Transaminases
1
2008
22
0.100
Why?
Renal Insufficiency
1
2010
119
0.100
Why?
Colorado
2
2010
4514
0.100
Why?
Vasoconstrictor Agents
1
2009
113
0.100
Why?
Heart Failure
2
2020
1806
0.100
Why?
Aged, 80 and over
8
2021
6709
0.090
Why?
Platelet Aggregation Inhibitors
3
2004
343
0.090
Why?
Alveolitis, Extrinsic Allergic
1
1989
79
0.090
Why?
Serotonin Plasma Membrane Transport Proteins
1
2009
108
0.090
Why?
Vasopressins
1
2009
141
0.090
Why?
Ventricular Dysfunction, Right
3
2009
193
0.090
Why?
Lung Diseases
2
2010
712
0.090
Why?
Ventricular Dysfunction, Left
1
2011
380
0.090
Why?
Hospitals, University
1
2008
193
0.090
Why?
Drug Costs
1
2008
88
0.090
Why?
Airway Obstruction
1
2009
151
0.090
Why?
Lupus Erythematosus, Systemic
3
2010
245
0.090
Why?
Endothelins
1
2007
63
0.090
Why?
Depressive Disorder, Major
1
2010
294
0.090
Why?
Kaplan-Meier Estimate
3
2018
858
0.090
Why?
Autoimmune Diseases
2
2005
427
0.090
Why?
Multivariate Analysis
4
2015
1597
0.090
Why?
Hypophosphatemia
1
2006
32
0.090
Why?
Drug Utilization
1
2008
189
0.090
Why?
Educational Measurement
1
1989
287
0.080
Why?
Hypokalemia
1
2006
32
0.080
Why?
Genetic Predisposition to Disease
3
2018
2368
0.080
Why?
Appetite Depressants
1
2006
20
0.080
Why?
Clinical Trials as Topic
2
2009
992
0.080
Why?
Child
6
2011
16586
0.080
Why?
Calcium Channel Blockers
1
2007
163
0.080
Why?
Phosphorus
1
2006
87
0.080
Why?
Potassium
1
2006
148
0.080
Why?
3',5'-Cyclic-GMP Phosphodiesterases
1
2005
17
0.080
Why?
Ventricular Function
1
2006
65
0.080
Why?
CREST Syndrome
2
2002
6
0.080
Why?
Arthritis, Rheumatoid
3
2010
867
0.080
Why?
Pleural Diseases
1
2005
22
0.080
Why?
Medical Informatics
1
2006
103
0.080
Why?
Retrospective Studies
6
2018
10640
0.080
Why?
Cattle
5
1994
997
0.080
Why?
Probability
3
2015
344
0.080
Why?
Referral and Consultation
1
2010
587
0.080
Why?
Forecasting
3
2021
390
0.070
Why?
Carbon Monoxide
2
2018
74
0.070
Why?
Predictive Value of Tests
3
2016
1999
0.070
Why?
Analysis of Variance
3
2009
1564
0.070
Why?
Immunohistochemistry
3
2005
1845
0.070
Why?
Recombinant Proteins
1
2008
1465
0.070
Why?
Terminology as Topic
1
2005
221
0.070
Why?
Age Distribution
3
2010
392
0.070
Why?
Sex Distribution
3
2010
389
0.070
Why?
Physicians, Family
1
2005
225
0.070
Why?
Heart Defects, Congenital
2
2009
736
0.070
Why?
Physician's Role
1
2005
212
0.070
Why?
Scleroderma, Localized
1
2002
6
0.070
Why?
Polymyositis
1
2002
14
0.070
Why?
Hypoxia
3
2018
934
0.070
Why?
Neoplasm Metastasis
1
2005
613
0.070
Why?
Dermatomyositis
1
2002
22
0.060
Why?
Serotonin Antagonists
1
2002
33
0.060
Why?
Thromboxane-A Synthase
1
2002
2
0.060
Why?
Statistics, Nonparametric
2
2003
470
0.060
Why?
Cardiac Surgical Procedures
1
2008
548
0.060
Why?
Clinical Competence
1
1989
881
0.060
Why?
Liver Function Tests
3
2011
132
0.060
Why?
Polymerase Chain Reaction
2
2003
1101
0.060
Why?
Multicenter Studies as Topic
2
2006
212
0.060
Why?
Animals
11
2013
34608
0.060
Why?
Biomarkers, Pharmacological
1
2021
28
0.060
Why?
Tricuspid Valve Insufficiency
2
2011
25
0.060
Why?
Drug Administration Schedule
4
2008
836
0.060
Why?
Enzyme Inhibitors
2
2004
933
0.060
Why?
Least-Squares Analysis
1
2021
82
0.060
Why?
Injections, Intravenous
2
2013
260
0.060
Why?
Walk Test
1
2021
49
0.060
Why?
Tropoelastin
2
1991
11
0.060
Why?
Injections, Subcutaneous
1
2021
169
0.060
Why?
Adjuvants, Immunologic
1
2002
239
0.060
Why?
Reproductive History
1
2020
13
0.060
Why?
Lung Diseases, Interstitial
1
2005
398
0.060
Why?
Polymorphism, Single Nucleotide
3
2018
2017
0.060
Why?
Europe
2
2012
344
0.060
Why?
Infusion Pumps
1
2000
35
0.050
Why?
Lymph Nodes
1
2003
464
0.050
Why?
Jaw
1
2000
21
0.050
Why?
Internship and Residency
1
1989
918
0.050
Why?
Cardiac Output
1
2020
170
0.050
Why?
Delivery of Health Care
1
2006
650
0.050
Why?
Risk
2
2015
950
0.050
Why?
Reproducibility of Results
2
2019
2840
0.050
Why?
Autoimmunity
1
2005
734
0.050
Why?
Cells, Cultured
5
1994
4343
0.050
Why?
Placebos
2
2011
221
0.050
Why?
Radiography
2
1995
863
0.050
Why?
Transplantation, Homologous
2
1998
503
0.050
Why?
Intramolecular Oxidoreductases
1
1999
65
0.050
Why?
Spinal Diseases
1
1999
44
0.050
Why?
Gonadal Steroid Hormones
1
2020
115
0.050
Why?
Symptom Assessment
1
2020
125
0.050
Why?
Thrombocytopenia
1
2021
177
0.050
Why?
Genotype
4
2009
2074
0.050
Why?
Genotyping Techniques
1
2018
84
0.050
Why?
Cytochrome P-450 Enzyme System
1
1999
151
0.050
Why?
Cervical Vertebrae
1
1999
108
0.050
Why?
Methicillin Resistance
1
1998
16
0.050
Why?
Plasmapheresis
1
1998
25
0.050
Why?
Pulmonary Diffusing Capacity
1
2018
58
0.050
Why?
Hemoptysis
1
1998
31
0.050
Why?
Child, Preschool
2
2011
9417
0.050
Why?
Bronchiolitis Obliterans
1
1998
68
0.050
Why?
Capillaries
1
1998
112
0.040
Why?
Gastrointestinal Diseases
1
2000
205
0.040
Why?
Disease-Free Survival
2
2010
668
0.040
Why?
alpha 1-Antitrypsin Deficiency
1
1998
76
0.040
Why?
Immunosuppressive Agents
3
1998
859
0.040
Why?
Cell Division
4
1994
871
0.040
Why?
Mass Screening
2
2018
990
0.040
Why?
Biomedical Technology
1
2017
44
0.040
Why?
Fatal Outcome
1
1998
311
0.040
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
1997
44
0.040
Why?
Network Meta-Analysis
1
2016
8
0.040
Why?
Faculty, Medical
2
1990
236
0.040
Why?
Blood Coagulation Factors
1
1996
37
0.040
Why?
Colonic Diseases
1
1996
32
0.040
Why?
Mycoplasma
1
1996
8
0.040
Why?
Health Status Indicators
2
2009
187
0.040
Why?
Intestinal Perforation
1
1996
49
0.040
Why?
Mycoplasma Infections
1
1996
16
0.040
Why?
Uric Acid
1
2000
329
0.040
Why?
Myosin Heavy Chains
1
1997
191
0.040
Why?
Translating
1
2016
36
0.040
Why?
Drug Hypersensitivity
1
1997
81
0.040
Why?
Cardiomyopathy, Dilated
1
1999
327
0.040
Why?
Dyspnea
2
2008
187
0.040
Why?
Comparative Effectiveness Research
1
2016
140
0.040
Why?
Down Syndrome
1
1999
268
0.040
Why?
Desensitization, Immunologic
1
1997
99
0.040
Why?
Cross-Sectional Studies
3
2016
3985
0.040
Why?
Pulmonary Emphysema
1
1998
296
0.040
Why?
Recurrence
1
1998
976
0.040
Why?
South Africa
1
2015
141
0.040
Why?
Lactobacillus
1
1994
23
0.040
Why?
Calibration
1
2015
149
0.040
Why?
Longitudinal Studies
2
2014
2634
0.040
Why?
Immunization, Passive
1
1994
72
0.040
Why?
Endothelium, Vascular
2
1994
953
0.040
Why?
Antisickling Agents
1
2014
6
0.040
Why?
Focus Groups
1
2016
350
0.040
Why?
Myocardium
2
1998
1103
0.040
Why?
Tetradecanoylphorbol Acetate
2
1994
172
0.040
Why?
Drug Approval
1
2015
72
0.040
Why?
Ferritins
1
2014
58
0.040
Why?
Hydroxyurea
1
2014
31
0.040
Why?
Staphylococcal Infections
1
1998
325
0.040
Why?
Immunoglobulins
1
1994
144
0.030
Why?
United States Food and Drug Administration
1
2015
173
0.030
Why?
Thyroiditis
1
1993
3
0.030
Why?
Raynaud Disease
1
1993
6
0.030
Why?
Fibrinolysis
1
1996
215
0.030
Why?
Cytomegalovirus
1
1994
144
0.030
Why?
Gram-Positive Bacterial Infections
1
1994
68
0.030
Why?
Pneumonia, Bacterial
1
1994
106
0.030
Why?
Administration, Intravenous
1
2014
138
0.030
Why?
Social Behavior
1
2016
312
0.030
Why?
Immunoenzyme Techniques
2
1994
227
0.030
Why?
Research
2
2009
441
0.030
Why?
Genome-Wide Association Study
1
2018
1073
0.030
Why?
Erythrocyte Indices
1
2012
29
0.030
Why?
Cytomegalovirus Infections
1
1994
187
0.030
Why?
Pulmonary Embolism
1
2015
177
0.030
Why?
Genetic Variation
1
2018
986
0.030
Why?
Blood Flow Velocity
1
2014
369
0.030
Why?
Creatinine
1
2014
444
0.030
Why?
Erythrocyte Transfusion
1
2014
188
0.030
Why?
Qualitative Research
1
2016
696
0.030
Why?
Embolism, Air
1
1992
9
0.030
Why?
Mental Health
1
2016
367
0.030
Why?
Emotions
1
2016
395
0.030
Why?
Enzyme Activation
2
1994
949
0.030
Why?
Cell-Derived Microparticles
1
2012
62
0.030
Why?
Signal Transduction
3
2018
4839
0.030
Why?
Biomedical Research
1
2017
597
0.030
Why?
Cardiomegaly
2
2006
173
0.030
Why?
Preoperative Care
2
2009
357
0.030
Why?
Homozygote
1
2011
192
0.030
Why?
Chronic Disease
2
2015
1650
0.030
Why?
Mortality
1
2012
305
0.030
Why?
Thromboxane B2
1
1989
25
0.030
Why?
Fellowships and Scholarships
2
1990
196
0.030
Why?
Calcimycin
1
1989
49
0.030
Why?
Decision Support Techniques
1
2014
374
0.030
Why?
Cystic Fibrosis
1
1998
772
0.030
Why?
Cost-Benefit Analysis
1
2012
522
0.030
Why?
Phenotype
3
2010
2968
0.030
Why?
Mutation
1
2020
3258
0.030
Why?
Angiopoietin-1
1
2009
9
0.030
Why?
Drug Synergism
1
1990
367
0.030
Why?
Cyclic Nucleotide Phosphodiesterases, Type 5
1
2009
23
0.020
Why?
Aromatase
1
2009
26
0.020
Why?
Pulmonary Veins
1
1989
80
0.020
Why?
Dyspepsia
1
2008
10
0.020
Why?
Health Policy
1
2012
347
0.020
Why?
Spironolactone
1
2009
38
0.020
Why?
Receptors, Retinoic Acid
1
2009
56
0.020
Why?
California
1
2010
377
0.020
Why?
Mineralocorticoid Receptor Antagonists
1
2009
57
0.020
Why?
Nucleic Acid Hybridization
1
1989
210
0.020
Why?
Health Care Costs
1
2012
384
0.020
Why?
Nitric Oxide
1
1994
890
0.020
Why?
Vital Capacity
1
2009
253
0.020
Why?
Cognition
1
2016
924
0.020
Why?
Hepatitis, Autoimmune
1
2008
30
0.020
Why?
Vibrio Infections
1
1987
2
0.020
Why?
Estrogen Receptor alpha
1
2009
105
0.020
Why?
Confidence Intervals
1
2009
345
0.020
Why?
Headache
1
2008
111
0.020
Why?
Endocarditis, Bacterial
1
1987
31
0.020
Why?
Calcium-Binding Proteins
1
2009
203
0.020
Why?
American Heart Association
1
2009
260
0.020
Why?
Echocardiography, Transesophageal
1
2009
134
0.020
Why?
In Vitro Techniques
1
1990
1285
0.020
Why?
Forced Expiratory Volume
1
2009
526
0.020
Why?
Down-Regulation
1
1990
681
0.020
Why?
Aminorex
1
2006
2
0.020
Why?
Protein Biosynthesis
1
1989
388
0.020
Why?
Magnetic Resonance Imaging
3
2006
2913
0.020
Why?
Hepatitis C
1
2008
196
0.020
Why?
Hypoventilation
1
1985
8
0.020
Why?
Heart Rate
1
2010
840
0.020
Why?
RNA, Messenger
2
1997
2885
0.020
Why?
Odds Ratio
1
2009
1046
0.020
Why?
Alleles
1
2009
897
0.020
Why?
Estradiol
1
2009
451
0.020
Why?
Maximum Tolerated Dose
1
2005
179
0.020
Why?
Magnesium
1
1985
150
0.020
Why?
Biopsy, Needle
1
2005
197
0.020
Why?
Critical Care
1
1989
466
0.020
Why?
Statistics as Topic
1
2006
371
0.020
Why?
Drug Prescriptions
1
2006
251
0.020
Why?
Hypotension
1
1985
113
0.020
Why?
Fibroblasts
1
1989
868
0.020
Why?
Pancreatic Elastase
1
2004
64
0.020
Why?
Bone Morphogenetic Protein Receptors, Type II
1
2004
43
0.020
Why?
Gene Expression Regulation
2
1997
2599
0.020
Why?
Tablets
1
2003
30
0.020
Why?
Research Design
1
2009
861
0.020
Why?
Aging
1
1994
1696
0.020
Why?
Potassium Channels
1
2004
132
0.020
Why?
Sensitivity and Specificity
1
2009
1931
0.020
Why?
Arginine
1
2004
230
0.020
Why?
Logistic Models
1
2009
2016
0.020
Why?
DNA
1
1990
1407
0.020
Why?
Angiotensin II
1
2003
114
0.020
Why?
Liver Transplantation
1
2009
756
0.020
Why?
Attitude of Health Personnel
1
2010
967
0.020
Why?
Sex Factors
1
2008
1949
0.020
Why?
Ovarian Neoplasms
1
2005
328
0.020
Why?
Sepsis
1
1987
475
0.010
Why?
Practice Patterns, Physicians'
1
2010
1182
0.010
Why?
Protein-Serine-Threonine Kinases
1
2004
601
0.010
Why?
Colorimetry
1
2000
13
0.010
Why?
Heart Ventricles
1
2006
723
0.010
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2004
394
0.010
Why?
Rats
2
2004
6619
0.010
Why?
Spinal Osteophytosis
1
1999
3
0.010
Why?
Spinal Cord Compression
1
1999
14
0.010
Why?
Spinal Stenosis
1
1999
28
0.010
Why?
Veins
1
1999
65
0.010
Why?
Heart Atria
1
2000
132
0.010
Why?
In Situ Hybridization
1
1999
365
0.010
Why?
Calcium-Transporting ATPases
1
1997
47
0.010
Why?
Atrial Natriuretic Factor
1
1997
68
0.010
Why?
Heart-Lung Transplantation
1
1997
35
0.010
Why?
Arteries
1
1999
218
0.010
Why?
Liver Cirrhosis
1
1999
191
0.010
Why?
Diverticulitis, Colonic
1
1996
7
0.010
Why?
Receptors, Adrenergic, beta
1
1997
157
0.010
Why?
Tissue Distribution
1
1997
407
0.010
Why?
Systole
1
1997
197
0.010
Why?
von Willebrand Factor
1
1996
57
0.010
Why?
Spinal Cord
1
1999
410
0.010
Why?
Models, Biological
1
2004
1869
0.010
Why?
Blotting, Western
1
1999
1342
0.010
Why?
Respiration
1
1996
212
0.010
Why?
Physical Fitness
1
1997
192
0.010
Why?
Cilazapril
1
1995
2
0.010
Why?
Electrophoresis, Agar Gel
1
1995
29
0.010
Why?
Proteins
2
1992
977
0.010
Why?
Ventricular Function, Left
1
1999
467
0.010
Why?
Tissue Donors
1
1997
304
0.010
Why?
Thymidine
1
1994
60
0.010
Why?
Ganciclovir
1
1994
52
0.010
Why?
Subcellular Fractions
1
1994
87
0.010
Why?
Opportunistic Infections
1
1994
55
0.010
Why?
Lung Diseases, Obstructive
1
1994
65
0.010
Why?
Blood
1
1994
96
0.010
Why?
Image Processing, Computer-Assisted
1
1999
726
0.010
Why?
Acyclovir
1
1994
119
0.010
Why?
Factor VIII
1
1994
53
0.010
Why?
Vimentin
1
1994
59
0.010
Why?
Viremia
1
1994
123
0.010
Why?
Immunoglobulins, Intravenous
1
1994
137
0.010
Why?
Liver
1
2002
1857
0.010
Why?
Heart
1
1997
685
0.010
Why?
Sputum
1
1994
274
0.010
Why?
Administration, Inhalation
1
1994
646
0.010
Why?
Immunocompromised Host
1
1994
219
0.010
Why?
Gene Expression
1
1998
1568
0.010
Why?
Neovascularization, Pathologic
1
1994
283
0.010
Why?
Blotting, Northern
1
1991
228
0.010
Why?
Lymph
1
1992
53
0.010
Why?
Antibodies, Viral
1
1994
484
0.010
Why?
Extracellular Matrix Proteins
1
1991
114
0.010
Why?
Flow Cytometry
1
1994
1166
0.010
Why?
Financing, Government
1
1990
51
0.010
Why?
National Institutes of Health (U.S.)
1
1990
106
0.010
Why?
Career Mobility
1
1990
81
0.010
Why?
Tomography, X-Ray Computed
1
1999
2385
0.010
Why?
Sheep
1
1992
737
0.010
Why?
Research Support as Topic
1
1990
125
0.010
Why?
Vibrio
1
1987
1
0.010
Why?
Pneumonia, Viral
1
1994
376
0.010
Why?
Hepatitis, Alcoholic
1
1987
6
0.010
Why?
Rats, Sprague-Dawley
1
1995
3196
0.010
Why?
Postoperative Complications
1
1997
2097
0.000
Why?
Citrates
1
1985
59
0.000
Why?
RNA
1
1991
762
0.000
Why?
Protein Binding
1
1992
2100
0.000
Why?
Anti-Bacterial Agents
1
1994
1280
0.000
Why?
Kidney Function Tests
1
1985
159
0.000
Why?
HIV Infections
1
1999
2358
0.000
Why?
Disease Models, Animal
1
1995
3843
0.000
Why?
Infant
1
1994
7798
0.000
Why?
Badesch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)